alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2022380EN.01000901.xml

| 3.10.2022 | EN | Official Journal of the European Union | C 380/9 |
| --- | --- | --- | --- |

3.10.2022

EN

Official Journal of the European Union

C 380/9

---

Action brought on 28 June 2022 — Bayerische Landesbank v SRB

(Case T-397/22)

(2022/C 380/11)

Language of the case: German

Parties

Applicant: Bayerische Landesbank (Munich, Germany) (represented by: H. Berger and W. Weber, lawyers)

Defendant: Single Resolution Board (SRB)

Form of order sought

The applicant claims that the Court should:

| — | annul the decision of the Single Resolution Board of 11 April 2022 on the calculation of the 2022 ex ante contributions to the Single Resolution Fund (SRB/ES/2022/18), including the annexes thereto, in so far as the contested decision, including Annex I, Annex II and Annex III thereto, concerns the applicant’s contribution; |
| --- | --- |

—

annul the decision of the Single Resolution Board of 11 April 2022 on the calculation of the 2022 ex ante contributions to the Single Resolution Fund (SRB/ES/2022/18), including the annexes thereto, in so far as the contested decision, including Annex I, Annex II and Annex III thereto, concerns the applicant’s contribution;

| — | order the defendant to pay the costs of the proceedings. |
| --- | --- |

—

order the defendant to pay the costs of the proceedings.

In the alternative, in the event that the Court takes the view that the contested decision is legally non-existent as a result of the use of the incorrect official language by the defendant and the action for annulment is therefore inadmissible on the ground that it is devoid of purpose, the applicant claims that the Court should:

| — | declare that the contested decision is legally non-existent; |
| --- | --- |

—

declare that the contested decision is legally non-existent;

| — | order the defendant to pay the costs of the proceedings. |
| --- | --- |

—

order the defendant to pay the costs of the proceedings.

Pleas in law and main arguments

The applicant relies on nine pleas in law which are essentially identical or similar to those relied on in Case T-396/22 Landesbank Baden-Württemberg v SRB.

---
Order filed, September 09, 2014.

In The

Fourteenth Court of Appeals

____________

NO. 14-14-00724-CR

____________

DAVID JAMES SIMMONS, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 339th District Court

Harris County, Texas

Trial Court Cause No. 1400879

ORDER

The reporter’s record in this case was due July 28, 2014. See Tex. R. App. 

P. 35.1. The court has not received a request to extend time for filing the record. 

The record has not been filed with the court. Because the reporter’s record has not 

been filed timely, we issue the following order.

We order Pam Knobloch, the official court reporter, to file the record in this 

appeal within 30 days of the date of this order. 

PER CURIAM
fs10214a1ex10xiii_dandrit.htm


Exhibit 10.13


 


LOAN AGREEMENT







Between 


Paseco ApS



c/o Crowe Horwath




Strandvejen 585


2900 Hellerup


CVR-nr: 31 36 36 08


 


And


 


Dandrit Biotech A/S


Symbian Sciencepark Fruebjergvej 3 


2100 Kebenhavn 0


CVR-nr. 26027322


 


(Paseco ApS and Dandrit Biotech A/S are individually referred to as "Party" and jointly as the "Parties")


 


Whereas:


 



A.  Dandrit Biotech A/S are in the process of raising new equity via a reverse merger into an USA company and subsequent listing in the US










B.  Paseco ApS has agreed to issue certain loans to Dandrit Biotech A/S to ensure sufficient equity in Dandrit Biotech A/S during the process, and










C.  Dandrit Biotech A/S has chosen to accept these loans




 




  





  











  






 


Now therefore, the parties have agreed as follows:


 



1.  The loans


 




Paseco ApS has agreed to issue the following loans to Dandrit Biotech A/S. 


DKK 2,500,000 issued as of February 15, 2014


DKK 2,300,000 issued as of March 18, 2014


 



2.  Interest




 


The loans will accrue interest at 5% per year as from the time where they are received by Dandrit Biotech and until repayment is done.


 



3.  Repayment




 


The loans are due 14 days after completion of the contemplated public offering in Dandrit Biotech USA, Inc. or February 1, 2015.


 


Dandrit Biotech is entitled to repay the loans at any time.


 



4.  Other provisions




 


This Agreement supersedes all previous agreements, written or oral, between the Parties.


 


This Agreement is made in English and signed by the Parties in two copies, one copy for each Party.



 




	DanDrit Biotech A/S	 	 	 	 
	Date: March 7, 2014	 	Date: March 21, 2014	 
	Signature:	

/s/ Eric Jean Marie Leire



	 	Signature:	

/s/ Niels Erik Nielsen



	 
	Mr. Eric Jean Marie Leire,	 	Mr. Niels Erik Nielsen,	 
	President and Chief Executive Officer	 	Chairman of the Board of Directors	 







 





	
Paseco ApS

	 
	
Date: March 17, 2014

	 
	Signature:	

/s/ Ole Abildgaard



	 
	Mr. Ole Abildgaard
ex10a.htm






















Exhibit 10(a)

















Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm












We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 21 to the 1933 Act Registration Statement (Form N-4 No. 333-141756) pertaining to Lincoln Life & Annuity Variable Annuity Account H, which is incorporated by reference into Post-Effective Amendment No. 22 to the 1933 Act Registration Statement (Form N-4 No. 333-141763) and Amendment No. 240 to the 1940 Act Registration Statement (Form N-4 No. 811-08441), and to the use therein of our reports dated (a) April 1, 2014, with respect to the financial statements of Lincoln Life & Annuity Company of New York and (b) April 1, 2014, with respect to the financial statements of Lincoln Life & Annuity Variable Annuity Account H for the registration of interests in a separate account under individual flexible payment deferred variable annuity contracts.








/s/ Ernst & Young LLP












Philadelphia, Pennsylvania


April 1, 2014
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the registrant's Form
10-QSB for the Quarter ended September 30, 2000 and is qualified in its entirety
to such form.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         667,529
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               685,667
<PP&E>                                          35,075
<DEPRECIATION>                                  17,490
<TOTAL-ASSETS>                                 706,292
<CURRENT-LIABILITIES>                          238,130
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     2,152,143
<OTHER-SE>                                   2,927,177
<TOTAL-LIABILITY-AND-EQUITY>                   706,292
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               502,632
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,817
<INCOME-PRETAX>                              (504,449)
<INCOME-TAX>                                     1,600
<INCOME-CONTINUING>                          (506,049)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (506,049)
<EPS-BASIC>                                     (0.01)
<EPS-DILUTED>                                   (0.01)


</TABLE>
116TH CONGRESS 

1ST SESSION H. R. 887 

AN ACT 

To designate the facility of the United States Postal Service 

located at 877 East 1200 South in Orem, Utah, as 

the ‘‘Jerry C. Washburn Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 887 EH

1 SECTION 1. JERRY C. WASHBURN POST OFFICE BUILDING. 

2 (a) DESIGNATION.—The facility of the United States 

3 Postal Service located at 877 East 1200 South in Orem, 

4 Utah, shall be known and designated as the ‘‘Jerry C. 

5 Washburn Post Office Building’’. 

6 (b) REFERENCES.—Any reference in a law, map, reg7 ulation, document, paper, or other record of the United 

8 States to the facility referred to in subsection (a) shall 

9 be deemed to be a reference to the ‘‘Jerry C. Washburn 

10 Post Office Building’’. 

Passed the House of Representatives October 16, 

2019. 

Attest: 

Clerk. 

116TH CONGRESS 

1ST SESSION H. R. 887 

AN ACT 

To designate the facility of the United States PostOffice Building’’. Orem, Utah, as the ‘‘Jerry C. Washburn Post al Service located at 877 East 1200 South in
**Exhibit
      31.2**




**CERTIFICATION**





I,
      Stephen Spitzer, as the acting Principal Financial Officer of PubliCARD, Inc.
      (the “Company”), certify that:




1.  I
      have
      reviewed this annual report on Form 10-K of the Company;





2.  Based
      on
      my knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this report;





3.  Based
      on
      my knowledge, the financial statements, and other financial information included
      in this report, fairly present in all material respects the financial condition,
      results of operations and cash flows of the registrant as of, and for, the
      periods presented in this report;





4.  I
      am
      responsible for establishing and maintaining disclosure controls and procedures
      (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) **** for
      the
      registrant and have:





(a)
      Designed such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under my supervision, to ensure that
      material information relating to the registrant, including its consolidated
      subsidiaries, is made known to me by others within those entities, particularly
      during the period in which this report is being prepared;





(b)
      Evaluated the effectiveness of the registrant’s disclosure controls and
      procedures and presented in this report my conclusions about the effectiveness
      of the disclosure controls and procedures, as of the end of the period covered
      by this report based on such evaluation; and





(c)
      Disclosed in this report any change in the registrant’s internal control over
      financial reporting that occurred during the registrant’s fourth fiscal quarter
      that has materially affected, or is reasonably likely to materially affect,
      the
      registrant’s internal control over financial reporting; and





5.  I
      have
      disclosed, based on my most recent evaluation of internal control over financial
      reporting, to the registrant’s auditors and the audit committee of the
      registrant’s board of directors (or persons performing the equivalent
      functions):





(a)  All
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant’s ability to record, process, summarize and
      report financial information; and





(b)  Any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in the registrant’s internal control over financial
      reporting.


Date:
                April 13, 2007
            
            
            /s/
                Stephen A. SpitzerStephen
                A. SpitzerActing
                Principal Financial Officer
CERTIFICATION OF CHIEF FINANCIAL OFFICER
                          OF CORPORATE GENERAL PARTNER

            PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The  undersigned,  Robert A. Bourne,  the  President and Treasurer of CNL Realty
Corporation,  the  corporate  general  partner of CNL Income Fund III, Ltd. (the
"Partnership"),  has executed this  certification  in connection with the filing
with the  Securities  and Exchange  Commission  of the  Partnership's  Quarterly
Report on Form 10-Q for the period  ending  March 31, 2004 (the  "Report").  The
undersigned hereby certifies that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) the  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and results of operations of the Partnership.


Date:  May 7, 2004                            /s/  Robert  A. Bourne
                                              ----------------------------------
                                              Name:   Robert  A.  Bourne  Title:
                                              President and Treasurer

                                              A signed  original of this written
                                              statement  required by Section 906
                                              has been  provided  to CNL  Income
                                              Fund   III,   Ltd.   and  will  be
                                              retained  by CNL Income  Fund III,
                                              Ltd.   and    furnished   to   the
                                              Securities and Exchange Commission
                                              or its staff upon request.
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,

 Plaintiff - Appellant,

 v.

JERMAINE EARL MCCLELLAND,

AKA Baby Mont, AKA Monty,

 Defendant - Appellee.

No. 13-50082

D.C. No. 2:12-cr-00872-R-1

MEMORANDUM*

Appeal from the United States District Court

for the Central District of California

Manuel L. Real, District Judge, Presiding

Submitted May 15, 2014** 

Pasadena, California

Before: KOZINSKI, Chief Judge, WARDLAW and FISHER, Circuit 

Judges.

The district court lacked authority to impose a sentence below the mandatory

minimum. See United States v. Wipf, 620 F.3d 1168, 1170–71 (9th Cir. 2010). 

FILED

MAY 21 2014

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

 * This disposition is not appropriate for publication and is not precedent

except as provided by 9th Cir. R. 36-3.

 ** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2).
page 2

Because McClelland had three criminal history points, he was ineligible for safety

valve relief. See 18 U.S.C. § 3553(f). Whether the district court believed that

McClelland’s criminal history category substantially over-represented the

seriousness of his criminal history is irrelevant because “district courts have no

authority to adjust criminal history points for the purpose of determining eligibility

for safety valve relief under 18 U.S.C. § 3553(f)(1).” United States v. HernandezCastro, 473 F.3d 1004, 1008 (9th Cir. 2007). We therefore vacate the sentence and

remand for resentencing.

VACATED AND REMANDED.
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 895 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
116th CONGRESS
  2d Session
                                H. R. 895

_______________________________________________________________________

                                 AN ACT

 
 To allow tribal grant schools to participate in the Federal Employee 
                        Health Benefits program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Tribal School Federal Insurance 
Parity Act''.

SEC. 2. AMENDMENT TO THE INDIAN HEALTH CARE IMPROVEMENT ACT.

    Section 409 of the Indian Health Care Improvement Act (25 U.S.C. 
1647b) is amended by inserting ``or the Tribally Controlled Schools Act 
of 1988 (25 U.S.C. 2501 et seq.)'' after ``(25 U.S.C. 450 et seq.)''.

            Passed the House of Representatives September 21, 2020.

            Attest:

                                                                 Clerk.
116th CONGRESS

  2d Session

                               H. R. 895

_______________________________________________________________________

                                 AN ACT

 To allow tribal grant schools to participate in the Federal Employee 
                        Health Benefits program.
```
#### Gurpreet SINGH, Petitioner, v. Jefferson B. SESSIONS III, Attorney General, Respondent.

No. 16-72041

United States Court of Appeals, Ninth Circuit.

Submitted February 13, 2018 *

Filed February 22, 2018

Margaret W. Wong, Esquire, Attorney, Margaret W. Wong & Associates, Cleveland, OH, for Petitioner

Surell Brady, Esquire, Trial Attorney, DOJ—U.S. Department of Justice, Civil Division/Office of Immigration Litigation, Washington, DC, Chief Counsel ICE, Office of the Chief Counsel, Department of Homeland Security, San Francisco, CA, for Respondent

Before: LEAVY, FERNANDEZ, and MURGUIA, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R. App. P. 34(a)(2).

MEMORANDUM **

Gupreet Singh, a native and citizen of India, petitions for review of the decision of the Board of Immigration Appeals (“BIA”) affirming an immigration judge’s (“IJ”) decision denying his application for asylum and withholding of removal. We have jurisdiction under 8 U.S.C. § 1252. We review for substantial evidence the agency’s factual findings, *Zehatye v. Gonzales,*453 F.3d 1182, 1184-85 (9th Cir. 2006), and we deny the petition for review.

Substantial evidence supports the agency’s finding that, although Singh established past persecution, the government rebutted Singh’s presumed well-founded fear of future persecution with evidence that he could safely and reasonably relocate within India to avoid harm. *See*8 C.F.R. § 1208.13(b)(3); *Gonzalez-Hernandez v. Ashcroft,*336 F.3d 995, 999 (9th Cir. 2003). We reject Singh’s contentions that the agency’s relocation analysis was insufficient and that the BIA failed to adequately address his argument that the IJ’s anal*572ysis was insufficient. Thus, his asylum claim fails.

In this case, because Singh failed to establish eligibility for asylum, he failed to satisfy the standard for withholding of removal. *See Zehatye,*463 F.3d at 1190.

PETITION FOR REVIEW DENIED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
I 

116TH CONGRESS 

1ST SESSION H. R. 907 

To clarify exclusions from the definition of a deposit broker. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 30, 2019 

Mr. LAHOOD (for himself and Mrs. BUSTOS) introduced the following bill; 

which was referred to the Committee on Financial Services 

A BILL 

To clarify exclusions from the definition of a deposit broker. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DEFINITION OF A DEPOSIT BROKER. 

4 Section 29(g)(2)(I) of the Federal Deposit Insurance 

5 Act (12 U.S.C. 1831f(g)(2)(I)) is amended to read as fol6 lows: 

7 ‘‘(I) an agent or nominee— 

8 ‘‘(i) whose primary purpose is not the 

9 placement of funds with depository institu10 tions; or 

11 ‘‘(ii) who is— 

12 ‘‘(I) an exclusive agent of— 


kjohnson on DSK79L0C42 with BILLS
2 

•HR 907 IH

1 ‘‘(aa) an insurance company; 

2 and 

3 ‘‘(bb) an insured depository 

4 institution affiliated with such in5 surance company; and 

6 ‘‘(II) is contractually prohibited 

7 by agreement with such depository in8 stitution from placing funds with any 

9 other unaffiliated depository institu10 tion and from acting as an agent of 

11 any other person with respect to any 

12 deposit or deposit account.’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1,000
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-26-1998             DEC-27-1997
<PERIOD-START>                             DEC-28-1997             DEC-29-1996
<PERIOD-END>                               MAR-28-1998             MAR-29-1997
<CASH>                                          34,049                  37,397
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  315,961                 191,327
<ALLOWANCES>                                     5,429                   4,788
<INVENTORY>                                    487,274                 359,492
<CURRENT-ASSETS>                               853,652                 596,358
<PP&E>                                          91,376                  67,077
<DEPRECIATION>                                  93,037                  62,936
<TOTAL-ASSETS>                               1,103,574                 760,293
<CURRENT-LIABILITIES>                          610,434                 508,351
<BONDS>                                        141,500                  55,250
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                         1,536                   1,123
<OTHER-SE>                                     346,085                 191,941
<TOTAL-LIABILITY-AND-EQUITY>                 1,103,574                 760,293
<SALES>                                      1,000,453                 841,690
<TOTAL-REVENUES>                             1,000,453                 841,690
<CGS>                                          918,416                 772,601
<TOTAL-COSTS>                                  918,416                 772,601
<OTHER-EXPENSES>                                58,430                  53,163
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                               7,532                   7,036
<INCOME-PRETAX>                                 16,075                   8,890
<INCOME-TAX>                                     6,591                   3,645
<INCOME-CONTINUING>                              9,484                   5,245
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                     9,484                   5,245
<EPS-PRIMARY>                                      .63                     .48
<EPS-DILUTED>                                      .54                     .42
        

</TABLE>